Mirae Asset Global ETFs Holdings
ZNTL icon

Mirae Asset Global ETFs Holdings’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112K Buy
+23,037
New +$92K ﹤0.01% 2767
2025
Q2 		– Sell
-34,202
Closed -$54.4K – 3272
2025
Q1 		$54.4K Buy
34,202
+1,488
+5% +$3.21K ﹤0.01% 2833
2024
Q4 		$99.1K Buy
32,714
+1,452
+5% +$4.76K ﹤0.01% 2701
2024
Q3 		$115K Sell
31,262
-4,333
-12% -$15.7K ﹤0.01% 2652
2024
Q2 		$146K Buy
+35,595
New +$398K ﹤0.01% 2410

Other funds holding ZNTL

5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ZNTL Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in Zentalis Pharmaceuticals (ZNTL) in Q2 2026: 23,037 shares worth $112K. The stake represents ﹤0.01% of the portfolio and ranks #2767 among its holdings. This is a return to the name: Mirae Asset Global ETFs Holdings previously reported a position in ZNTL as recently as Q1 2025.

Mirae Asset Global ETFs Holdings first reported a position in ZNTL in Q2 2024 and has held it in 5 quarters since. The position peaked at $146K in Q2 2024. 114 funds tracked by Wall St. Rank hold ZNTL as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 23,037 shares of Zentalis Pharmaceuticals worth $112K as of Q2 2026.
  • Zentalis Pharmaceuticals was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
  • Zentalis Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2767 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Zentalis Pharmaceuticals in Q2 2024 and has held it in 5 quarters since.
  • Mirae Asset Global ETFs Holdings's Zentalis Pharmaceuticals position peaked at $146K in Q2 2024.
  • 114 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.